GLOBAL BIOPSY DEVICES MARKET SIZE

Global Biopsy Devices Market Size According to BlueWeave Consulting, Global Biopsy Devices Market is estimated to be USD 3.8 billion by 2026 from USD 2.53 billion in 2019, at a CAGR of 6% from 2020 to 2026. A biopsy is a type of process to eliminate a piece of tissue or a sample of cells from a patient’s body. It is majorly used to extract tissue samples for finding and definitively recognize cancerous tissue and cells. The global market for biopsy devices is rising rapidly. The market is increasing the occurrence of cancer and the continually growing need for high-worth diagnostic and therapeutic procedures are majorly accountable for the development of the global biopsy devices market. Also, the rising awareness concerning cancer treatment and diagnosis will support the increase in the biopsy devices market size in the forthcoming years. Many countries hold courses for the early diagnosis of breast cancer. Therefore, such initiatives will accelerate the acceptance rate of biopsy devices, thereby positively impacting the growth of the biopsy devices business in the predictable future. North America is found to be the leading revenue contributor in the market. The well-known market players in the region will continue to account for a considerable share in the market throughout the forecast period “The Breast Biopsy dominates the Application Segment” Based on the application, the market is classified into breast biopsy, gastrointestinal (GI) biopsy, prostate biopsy, liver biopsy, lung biopsy, kidney biopsy, gynecological biopsy, and others. Based on the application, the breast biopsy in the application segment generated the highest revenue in 2018 and is expected to maintain its supremacy during the forecast period. This is attributed to the rise in the number of breast cancer patients witnessed over the years throughout the globe and is predictable to maintain this trend in the future. Presently, breast cancer can be recognized efficiently using progressive biopsy devices with higher efficacy in less time. Growth Drivers Rising cases of cancer The growing occurrence of cancer universal and the occurrence of untapped opportunities in developing economies, especially of Asia Pacific, along with refining healthcare infrastructure in these regions, are amid the key trends stoking market

growth. Surging demand for effective diagnostic procedures for cancer is also predictable to work in favor of the market. R&D in the medical field The outline of technologically advanced products such as the Aspiration biopsy syringe gun by INRAD Inc. supports the section's development. Moreover, the burgeoning demand for vacuum-assisted devices is inducing the biopsy devices market positively. These devices are manual, semi-automatic, and automatic with a spring-loaded mechanism for minimally invasive insertion to obtain laboratory testing samples. Such devices prove high efficiency and accuracy in the withdrawal of large volumes and excellent quality tissue samples with minimal passes through the skin. About Us BlueWeave Consulting is a one-stop solution for market intelligence regarding various products and services online & offline. We offer comprehensive market research reports by analyzing both qualitative and quantitative data to boost up the performance of your business solution. BWC has built its reputation from the scratches by delivering quality performance and nourishing long-lasting relationships with its clients. We are one of the promising digital market intelligence generation company providing unique solutions for blooming your business and making the morning, more rising & shining. More:https://www.blueweaveconsulting.com/press-release/global-biopsy-devices- market BLUEWEAVE CONSULTING Office-112-H160-BSI Business Park Sector 63 Noida-U.P. [email protected] +18666586826 | +1425304776 www.blueweaveconsulting.com